Randomised trial of the P2X(3) receptor antagonist sivopixant for refractory chronic cough

por Niimi, Akio, Saito, Junpei, Kamei, Tadashi, Shinkai, Masaharu, Ishihara, Hiroyuki, Machida, Mitsuaki, Miyazaki, Sayaka
Publicado 2022

666. Efficacy and Safety of Cefiderocol According to Renal Impairment in Patients With Complicated Urinary Tract Infection (cUTI) in a Phase 2 Study

por Portsmouth, Simon, Echols, Roger, Machida, Mitsuaki, Camilo Arjona Ferreira, Juan, Ariyasu, Mari, Den Nagata, Tsutae
Publicado 2019

A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2b Trial of P2X3 Receptor Antagonist Sivopixant for Refractory or Unexplained Chronic Cough

por McGarvey, Lorcan, Smith, Jaclyn A., Morice, Alyn, Birring, Surinder S., Chung, Kian Fan, Dicpinigaitis, Peter V., Niimi, Akio, Benninger, Michael S., Sher, Mandel, Matsunaga, Yuko, Miyazaki, Sayaka, Machida, Mitsuaki, Ishihara, Hiroyuki, Mahmood, Adnan, Gomez, Juan-Carlos
Publicado 2022